Search results for "From ACP Internist Weekly"


 
Results 31 - 40 of about 60 for "From ACP Internist Weekly".
Sort by: Relevance | Newest | Oldest

Guidelines update management of eosinophilic esophagitis

Recommendations from the American Gastroenterological Association and the Joint Task Force for Allergy-Immunology Practice Parameters cover use of proton-pump inhibitors, steroids, diets, and endoscopic dilation.
https://gastroenterology.acponline.org/archives/2020/05/22/6.htm
22 May 2020

Acupuncture may offer some relief for postprandial distress syndrome, study finds

Patients were significantly more likely to report that their postprandial distress syndrome “extremely improved” or “improved” if they received acupuncture for 12 weeks rather than a sham treatment, a Chinese study found.
https://gastroenterology.acponline.org/archives/2020/05/22/7.htm
22 May 2020

USPSTF expands hepatitis C screening recommendation to most adults

All adults ages 18 to 79 years should now be screened at least once, but people who use injection drugs and pregnant women may require screening more often.
https://gastroenterology.acponline.org/archives/2020/03/27/6.htm
27 Mar 2020

Middle-age adults getting less colorectal cancer screening than retirement-age adults

Specific population-based efforts to increase colorectal cancer screening are needed so that patients start at age 50 years and continue through age 75 years for the most benefit, study authors said.
https://gastroenterology.acponline.org/archives/2020/03/27/7.htm
27 Mar 2020

AGA releases guidelines on managing gastric intestinal metaplasia found during routine endoscopy

The guidelines from the American Gastroenterological Association (AGA) will aid clinicians' decision making for patients undergoing upper endoscopy in North America, the authors said.
https://gastroenterology.acponline.org/archives/2019/12/27/7.htm
27 Dec 2019

ACP issues new guidance on colorectal cancer screening

For asymptomatic, average-risk patients ages 50 to 75 years, the guidance suggests use of a fecal immunochemical test (FIT) or high-sensitivity guaiac-based fecal occult blood test every two years, colonoscopy every 10 years, or flexible sigmoidoscopy every 10 years plus FIT every two years.
https://gastroenterology.acponline.org/archives/2019/11/22/8.htm
22 Nov 2019

Model supports high-intensity surveillance after detection of colorectal adenomas

The target population was U.S. patients ages 50, 60, or 70 years with low-risk or high-risk adenomas removed after screening via colonoscopy or fecal immunochemical testing.
https://gastroenterology.acponline.org/archives/2019/09/27/10.htm
27 Sep 2019

Lipophilic statins associated with significantly reduced hepatocellular carcinoma incidence, mortality in hepatitis

Potential benefits of lipophilic statins appeared to be dose- and duration-dependent, with the greatest reduction in hepatocellular carcinoma risk seen with use of a moderate-dose statin for about two years, according to data from a registry of Swedish patients with hepatitis B or C.
https://gastroenterology.acponline.org/archives/2019/08/23/7.htm
23 Aug 2019

Financial incentives associated with increased FIT uptake but not increased CRC screening overall

A three-arm trial of incentives for fecal immunochemical testing (FIT) and colorectal cancer screening (CRC) tested mail-only, mail and monetary, and mail and lottery interventions.
https://gastroenterology.acponline.org/archives/2019/07/26/7.htm
26 Jul 2019

Time of day associated with ordering, completion of cancer screening

An editorial noted that referrals to screening could be handled by other clinic staff, easing the burden on physicians.
https://gastroenterology.acponline.org/archives/2019/05/24/7.htm
24 May 2019

Result Page: Prev   1   2   3   4   5   6   Next